Waters Corporation (NYSE:WAT) has been given an average recommendation of “Hold” by the fourteen research firms that are covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a sell recommendation, five have issued a hold recommendation, six have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $186.00.

Several research firms have issued reports on WAT. Zacks Investment Research raised Waters Corporation from a “hold” rating to a “buy” rating and set a $202.00 price target for the company in a report on Thursday, July 13th. BidaskClub raised Waters Corporation from a “buy” rating to a “strong-buy” rating in a report on Wednesday, August 16th. Jefferies Group LLC reissued a “hold” rating and set a $175.00 price target on shares of Waters Corporation in a report on Thursday, July 27th. Morgan Stanley reissued an “underweight” rating and set a $183.00 price target (up previously from $174.00) on shares of Waters Corporation in a report on Wednesday, July 26th. Finally, Deutsche Bank AG lowered Waters Corporation from a “buy” rating to a “hold” rating and boosted their price target for the company from $183.00 to $194.00 in a report on Monday, July 10th.

In related news, Director Christopher A. Kuebler sold 3,500 shares of the business’s stock in a transaction dated Tuesday, August 8th. The stock was sold at an average price of $179.67, for a total value of $628,845.00. Following the sale, the director now directly owns 17,849 shares in the company, valued at $3,206,929.83. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 5.07% of the stock is currently owned by insiders.

Large investors have recently bought and sold shares of the stock. Fundsmith LLP lifted its position in shares of Waters Corporation by 11.3% in the first quarter. Fundsmith LLP now owns 3,432,535 shares of the medical instruments supplier’s stock worth $536,540,000 after buying an additional 349,178 shares in the last quarter. TIAA CREF Investment Management LLC lifted its position in shares of Waters Corporation by 42.7% in the first quarter. TIAA CREF Investment Management LLC now owns 375,413 shares of the medical instruments supplier’s stock worth $58,681,000 after buying an additional 112,335 shares in the last quarter. Aviva PLC lifted its position in shares of Waters Corporation by 0.9% in the second quarter. Aviva PLC now owns 47,903 shares of the medical instruments supplier’s stock worth $8,806,000 after buying an additional 420 shares in the last quarter. State Street Corp lifted its position in shares of Waters Corporation by 1.7% in the first quarter. State Street Corp now owns 3,446,000 shares of the medical instruments supplier’s stock worth $538,641,000 after buying an additional 58,746 shares in the last quarter. Finally, Lowe Brockenbrough & Co. Inc. lifted its position in shares of Waters Corporation by 1.1% in the first quarter. Lowe Brockenbrough & Co. Inc. now owns 1,516 shares of the medical instruments supplier’s stock worth $237,000 after buying an additional 16 shares in the last quarter. Institutional investors own 91.12% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This news story was first posted by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another website, it was copied illegally and reposted in violation of US & international trademark and copyright law. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2017/09/09/waters-corporation-wat-given-consensus-rating-of-hold-by-analysts.html.

Shares of Waters Corporation (NYSE WAT) opened at 186.56 on Friday. Waters Corporation has a one year low of $133.35 and a one year high of $187.65. The stock has a market cap of $14.89 billion, a PE ratio of 28.12 and a beta of 0.83. The company’s 50-day moving average price is $179.49 and its 200-day moving average price is $172.27.

Waters Corporation (NYSE:WAT) last released its quarterly earnings results on Tuesday, July 25th. The medical instruments supplier reported $1.76 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.71 by $0.05. Waters Corporation had a return on equity of 23.91% and a net margin of 24.26%. The business had revenue of $558.30 million during the quarter, compared to analyst estimates of $553.22 million. During the same quarter in the previous year, the company posted $1.58 earnings per share. Waters Corporation’s revenue for the quarter was up 4.0% on a year-over-year basis. Equities research analysts anticipate that Waters Corporation will post $7.38 earnings per share for the current year.

About Waters Corporation

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Analyst Recommendations for Waters Corporation (NYSE:WAT)

Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with MarketBeat.com's FREE daily email newsletter.